logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Acute Promyelocytic Leukemia

    FiltersReset Filters
    3 results

    • arsenic trioxide

      (arsenic trioxide)
      Ingenus Pharmaceuticals, LLC
      Usage: Arsenic trioxide injection is indicated for the induction of remission and consolidation in patients with relapsed or refractory acute promyelocytic leukemia (APL), particularly those who have a positive t(15;17) translocation or PML/RAR-alpha gene expression, and have not responded to retinoid and anthracycline chemotherapy.

    • tretinoin

      (Tretinoin)
      Par Pharmaceutical, Inc.
      Usage: Tretinoin capsules are indicated for inducing remission in adults and children aged 1 year and older with acute promyelocytic leukemia (APL) that has the t(15;17) translocation or PML/RARα gene expression, particularly in those refractory to or relapsed from anthracycline chemotherapy or when this chemotherapy is not suitable.

    • vesanoid

      (Tretinoin)
      V2 Pharma, LLC
      Usage: VESANOID is indicated for inducing remission in adults and pediatric patients (1 year and older) with acute promyelocytic leukemia (APL) characterized by t(15;17) translocation or PML/RARα gene expression, who are refractory or have relapsed from anthracycline chemotherapy, or when such chemotherapy is contraindicated.